Literature DB >> 12734288

Infection with an extended-spectrum beta-lactamase-producing strain of Serratia marcescens following tongue reconstruction.

Benu Dhawan1, Richard Bonnet, N K Shukla, Purva Mathur, Bimal K Das, Arti Kapil.   

Abstract

We report a case of postsurgical wound infection of polymicrobial etiology caused by Serratia marcescens and Pseudomonas aeruginosa following the use of a radial forearm free flap for oncological tongue reconstruction. S. marcescens was a producer of SHV-12 extended-spectrum beta-lactamase (ESBL). This is the first report from India of this ESBL. S. marcescens and P. aeruginosa were resistant to the empirical perioperative antibiotics administered. Delay in the recognition of the type of infection and in the institution of appropriate therapy resulted in total loss of the free flap.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12734288      PMCID： PMC154676          DOI： 10.1128/JCM.41.5.2233-2234.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1.

Authors:  A Karim; L Poirel; S Nagarajan; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  2001-07-24       Impact factor: 2.742

2.  Prophylactic antibiotics for head and neck surgery with flap reconstruction.

Authors:  J T Johnson; R L Wagner; D E Schuller; J Gluckman; J Y Suen; N L Snyderman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-05

Review 3.  An outbreak of extended-spectrum, beta-lactamase-producing Salmonella senftenberg in a burns ward.

Authors:  G Revathi; K P Shannon; P D Stapleton; B K Jain; G L French
Journal:  J Hosp Infect       Date:  1998-12       Impact factor: 3.926

4.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery.

Authors:  J T Johnson; V L Yu; E N Myers; R L Wagner
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226

Review 6.  Serratia marcescens infections.

Authors:  J F Acar
Journal:  Infect Control       Date:  1986-05

Review 7.  Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.

Authors:  J D Pitout; C C Sanders; W E Sanders
Journal:  Am J Med       Date:  1997-07       Impact factor: 4.965

8.  Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Authors:  R Bonnet; C Dutour; J L Sampaio; C Chanal; D Sirot; R Labia; C De Champs; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

9.  Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital.

Authors:  Purva Mathur; Arti Kapil; Bimal Das; Benu Dhawan
Journal:  Indian J Med Res       Date:  2002-04       Impact factor: 2.375

10.  Microvascular free flaps in head and neck reconstruction. Report of 200 cases and review of complications.

Authors:  M L Urken; H Weinberg; D Buchbinder; J F Moscoso; W Lawson; P J Catalano; H F Biller
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-06
  10 in total
  5 in total

1.  Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.

Authors:  J Delmas; F Robin; F Carvalho; C Mongaret; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Non-pigmented strain of serratia marcescens: an unusual pathogen causing pulmonary infection in a patient with malignancy.

Authors:  Priyamvada Roy; Nishat Hussain Ahmed; R K Grover
Journal:  J Clin Diagn Res       Date:  2014-06-20

3.  Emergence of metallo-β-lactamase GIM-1 in a clinical isolate of Serratia marcescens.

Authors:  Heime Rieber; Andre Frontzek; Yvonne Pfeifer
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

4.  Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India.

Authors:  Vikas Gautam; Anjana Thakur; Megha Sharma; Avinash Singh; Shruti Bansal; Aditi Sharma; Arti Kapil; Bimal Kumar Das; Sujatha Sistla; Subhash Chandra Parija; Balaji Veeraraghavan; John Antony Jude Prakash; Kamini Walia; V C Ohri; Pallab Ray
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

5.  Extended-Spectrum Beta-lactamase Producers: Detection for the Diagnostic Laboratory.

Authors:  Rani Diana Sahni; Dilip Mathai; Thambu David Sudarsanam; V Balaji; K N Brahamadathan; Mary V Jesudasan; M K Lalitha
Journal:  J Glob Infect Dis       Date:  2018 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.